Development of aggressive squamous cell carcinoma in epidermodysplasia verruciformis associated with human papillomavirus type 22b

Dermatology

Volumn 220, Issue 4, 2010, Pages 326-328

  Kim, Taegyun ^a   Park, Jae Chan ^c,d   Roh, Mi Ryung ^a   Park, Jin Mo ^a   Kim, Se Heon ^b   Cho, Nam Hoon ^a   Lee, Min Geol ^a  

^a Yonsei University College of Medicine   (South Korea)

^b Department of Otorhinolaryngology ^*  (South Korea)

^c Bio Core Co   (South Korea)

^d Hanyang University   (South Korea)

Author keywords

Aggressive squamous cell carcinoma; Epidermodysplasia verruciformis; Human papillomavirus type 22b; Papillomavirus

Indexed keywords

ADULT; ARTICLE; CANCER GROWTH; CANCER RADIOTHERAPY; CASE REPORT; CERVICAL LYMPH NODE; COPY NUMBER VARIATION; DISEASE ASSOCIATION; DNA EXTRACTION; DNA SEQUENCE; EPIDERMODYSPLASIA VERRUCIFORMIS; HISTOPATHOLOGY; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 22B; HUMAN TISSUE; LYMPH NODE METASTASIS; MALE; MAXILLARY SINUS; NASAL BONE; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEOTIDE SEQUENCE; POSTOPERATIVE CARE; PRIORITY JOURNAL; RADIATION DOSE; SQUAMOUS CELL CARCINOMA; WART VIRUS; CARCINOMA, SQUAMOUS CELL; CLASSIFICATION; COMPLICATION; GENETICS; ISOLATION AND PURIFICATION; NOSE NEOPLASMS; PAPILLOMA VIRUS; PATHOLOGY; SKIN NEOPLASMS; VIROLOGY;

ADULT; CARCINOMA, SQUAMOUS CELL; EPIDERMODYSPLASIA VERRUCIFORMIS; HUMANS; MALE; NOSE NEOPLASMS; PAPILLOMAVIRIDAE; SKIN NEOPLASMS;

EID: 77954243479     PISSN: 10188665     EISSN: None     Source Type: Journal    
DOI: 10.1159/000290759     Document Type: Article

References (19)

1. Rajagopalan K, Bahru J, Loo DS, Tay CH, Chin KN, Tan KK: Familial epidermodysplasia verruciformis of Lewandowsky and Lutz. Arch Dermatol 1972; 105: 73-78.
2. Orth G: Genetics of epidermodysplasia verruciformis: insights into host defense against papillomaviruses. Semin Immunol 2006; 18: 362-374.
3. de Oliveira WR, Festa Neto C, Rady PL, Tyring SK: Clinical aspects of epidermodysplasia verruciformis. J Eur Acad Dermatol Venereol 2003; 17: 394-398.
4. Pfister H: Chapter 8: Human papillomavirus and skin cancer. J Natl Cancer Inst Monogr 2003;31: 52-56.
5. Feltkamp MC, de Koning MN, Bavinck JN, Ter Schegget J: Betapapillomaviruses: innocent bystanders or causes of skin cancer. J Clin Virol 2008; 43: 353-360.
6. Asgari MM, Kiviat NB, Critchlow CW, Stern JE, Argenyi ZB, Raugi GJ, Berg D, Odland PB, Hawes SE, de Villiers EM: Detection of human papillomavirus DNA in cutaneous squamous cell carcinoma among immunocompetent individuals. J Invest Dermatol 2008; 128: 1409-1417.
7. Forslund O, Iftner T, Andersson K, Lindelof B, Hradil E, Nordin P, Stenquist B, Kirnbauer R, Dillner J, de Villiers EM: Cutaneous human papillomaviruses found in sun-exposed skin: beta-papillomavirus species 2 predominates in squamous cell carcinoma. J Infect Dis 2007; 196: 876-883.
8. Hazard K, Eliasson L, Dillner J, Forslund O: Subtype hpv38b[fa125] demonstrates heterogeneity of human papillomavirus type 38. Int J Cancer 2006; 119: 1073-1077.
9. Lindh M, Gorander S, Andersson E, Horal P, Mattsby-Balzer I, Ryd W: Real-time Taqman PCR targeting 14 human papillomavirus types. J Clin Virol 2007; 40: 321-324.
10. Cooper KD, Androphy EJ, Lowy D, Katz SI: Antigen presentation and T-cell activation in epidermodysplasia verruciformis. J Invest Dermatol 1990; 94: 769-776.
11. Lazarczyk M, Pons C, Mendoza JA, Cassonnet P, Jacob Y, Favre M: Regulation of cellular zinc balance as a potential mechanism of ever-mediated protection against pathogenesis by cutaneous oncogenic human papillomaviruses. J Exp Med 2008; 205: 35-42.
12. Jablonska S, Dabrowski J, Jakubowicz K: Epidermodysplasia verruciformis as a model in studies on the role of papovaviruses in oncogenesis. Cancer Res 1972; 32: 583-589.
13. Berkhout RJ, Bouwes Bavinck JN, ter Schegget J: Persistence of human papillomavirus DNA in benign and (pre)malignant skin lesions from renal transplant recipients. J Clin Microbiol 2000; 38: 2087-2096.
14. Weissenborn SJ, Nindl I, Purdie K, Harwood C, Proby C, Breuer J, Majewski S, Pfister H, Wieland U: Human papillomavirus-DNA loads in actinic keratoses exceed those in non-melanoma skin cancers. J Invest Dermatol 2005; 125: 93-97.
15. Jackson S, Harwood C, Thomas M, Banks L, Storey A: Role of Bak in UV-induced apoptosis in skin cancer and abrogation by HPV E6 proteins. Genes Dev 2000; 14: 3065-3073.
16. Bouwes Bavinck JN, Plasmeijer EI, Feltkamp MC: Beta-papillomavirus infection and skin cancer. J Invest Dermatol 2008; 128: 1355-1358.
17. Bogdan I, Scharer L, Rudlinger R, Hafner J: Epidermodysplasia verruciformis in two brothers developing aggressive squamous cell carcinoma. Dermatol Surg 2007; 33: 1525-1528.
18. Gul U, Kilic A, Gonul M, Cakmak SK, Bayis SS: Clinical aspects of epidermodysplasia verruciformis and review of the literature. Int J Dermatol 2007; 46: 1069-1072.
19. St-Pierre S, Baker SR: Squamous cell carcinoma of the maxillary sinus: analysis of 66 cases. Head Neck Surg 1983; 5: 508-513.